FDA Approved: EMTRIVA — Supplemental Application (Gilead Sciences, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for EMTRIVA (emtricitabine) filed by Gilead Sciences, Inc., updating the drug's labeling and/or indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Emtriva (emtricitabine)

Snippet

SUPPL AP for EMTRIVA (EMTRICITABINE)